期刊文献+

两种秋水仙碱醇质体的制备及评价 被引量:7

Preparation and Evaluation of Two Kinds of Colchicines Ethosomes
原文传递
导出
摘要 目的比较分别用不饱和磷脂和饱和磷脂为膜材,不同溶剂制得的秋水仙碱醇质体理化特性的差别。方法采用注入法制备秋水仙碱醇质体,正交设计法筛选处方。比较不饱和磷脂与饱和磷脂对其形态学、包封率、稳定性和经皮渗透的累积透过量的影响。结果制备的两种醇质体形状呈圆球形或类圆形,结构完整。含不饱和磷脂醇质体平均粒径为100 nm,粒径分布较窄,包封率达58%;含饱和磷脂醇质体平均粒径为50 nm,粒径分布较宽,包封率达63%;含饱和磷脂醇质体的稳定性受高温和光照的影响都要明显小于含不饱和磷脂醇质体。含饱和磷脂醇质体的药物单位面积累计透过量和药物在皮肤中的滞留量也明显高于含不饱和磷脂醇质体的透过量和滞留量。结论经初步评价,用氢化磷脂、乙醇和Tween 80所制备的秋水仙碱醇质体在包封率、稳定性和经皮渗透的累积透过量方面明显优于用大豆磷脂和异丙醇所制备的秋水仙碱醇质体。 OBJECTIVE To compare the difference of characteristics of colchicines ethosomes that made by soybean phospholipids or hydrogenated phosphatidylcholines.METHODS Colchicines ethosomes were prepared by injection method.The best prescription were screened out by an orthogonal design test.To compare the influence of soybean phospholipids and hydrogenated phosphatidylcholines at morphology、entrapment efficiency,stability,respectively.The difference of transdermal penetration rate were also studied.RESULTS The ethosomes with spherical or ellipsoidal shape.The particle size of colchicines ethosomes made by soybean phospholipids were 100 nm with a narrow range of size distribution.The entrapment efficiency were 58%.The particle size of colchicines ethosomes made by hydrogenated phosphatidylcholines were 50 nm with a wide range of size distribution.The entrapment efficiency were 63%.No obvious changes were found in all the indices in the stability test of the ethosomes made by hydrogenated phosphatidylcholines.Better than the ethosomes made by soybean phospholipids.So did in the transdermal penetration test.CONCLUSION By primary study,colchicines ethosomes made by hydrogenated phosphatidylcholines is better than colchicines ethosomes made by soybean phospholipids at entrapment efficiency、stability、 transdermal penetration test.
出处 《中国药学杂志》 CAS CSCD 北大核心 2010年第11期844-848,共5页 Chinese Pharmaceutical Journal
关键词 秋水仙碱 醇质体 大豆磷脂 氢化磷脂 colchicines ethosomes soybean phospholipids hydrogenated phosphatidylcholines
  • 相关文献

参考文献4

二级参考文献17

共引文献30

同被引文献65

  • 1牛文凯,邱泽武.秋水仙碱中毒的诊断与处理[J].药物不良反应杂志,2006,8(5):368-369. 被引量:37
  • 2中国药典[S].2010年版.二部.附录ⅨJ.
  • 3Sintov AC, Shapiro L. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo [ J ]. J Control Release, 2004,95 (2) :173-183.
  • 4Mustafa MA, Ossama AY, Viviane NF. Lipid vesicles for skin delivery of drugs: Reviewing three decades of research [ J]. International Journal of Pharmaceutics ,2007, 332 : 1-16.
  • 5Touitou E, Dayan N. Ethosomes novel vesicular carriers for enhanced delivery: characterization and skin penetration properties [ J ]. Journal of Controlled Release, 2000,65:403-418.
  • 6Vaibhav D, Dinesh M ,Tathagata D. Melatonin loaded ethanolic liposomes: Physicochemical characterization and enhanced transdermal delivery [ J ]. European JoumaF of Pharmaceutics and Biopharmaceutics,2007 ,67 :398-405.
  • 7Donatella P, Giuseppe D, Domenico M,et al. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers [ J ]. Journal of Controlled Release, 2005,106:99-110.
  • 8Subheet J, Ashok KT, Bharti S. Formulation and Evaluation of Ethosomes for Transdermal Delivery of Lamivudine [ J]. AAPS PharmSciTech, 2007,4( 8 ): 111.
  • 9Zhao WZ. Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats[ J]. J Liposome Res ,2009,24 : 1-8.
  • 10Tadros MI, Ehab R. Enhanced Transdermal Delivery of Salbutamol Sulfate via Ethosomes [ J ]. AAPS Pharm- SciTech, 2007,4 ( 8 ) : 107.

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部